Clarithromycin, a semisynthetic macrolide antibiotic derived from erythromycin, inhibits bacterial protein synthesis by binding to the bacterial 50S ribosomal subunit.
Clarithromycin Tablets are indicated for the treatment of infections caused by susceptible organisms. Indications include lower respiratory tract infections, such as pneumonia and acute and chronic bronchitis, and upper respiratory tract infections, such as sinusitis and pharyngitis; also to help prevent opportunistic infection with Mycobacterium in people with HIV, and prevent peptic ulcers caused by infection with Helicobacter pylori.

The global Clarithromycin Tablets market is valued at xx million US$ in 2020 is expected to reach xx million US$ by the end of 2026, growing at a CAGR of xx% during 2021-2026.
This report focuses on Clarithromycin Tablets volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Clarithromycin Tablets market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Clarithromycin Tablets market is segmented into
250 mg Tablets
500 mg Tablets

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Clarithromycin Tablets Market: Regional Analysis
The Clarithromycin Tablets market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Clarithromycin Tablets market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Clarithromycin Tablets Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Clarithromycin Tablets market include:
Abbvie
Abbott
Mylan
Apotex
Sandoz
Takeda Pharmaceuticals
Teva Pharmaceutical
Sun Pharmaceutical
Aurobindo Pharma
Mayne Pharma
Jiangsu Hengrui Medicine